HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2024 and to consider the declaration of dividend , if any, on the equity shares of the Company for the financial year 2023-24.